ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2026
Concurrent mental health and substance use disorders among Canadian adults during the COVID-19 pandemic: a population-based study.
Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionConcurrent disorders, defined here as co-occurring mental health disorders (MHD) and substance use disorders (SUD), pose challenges for treatment and public health. This study examines the prevalence and characteristics associated with MHD only, SUD only, and concurrent disorders among Canadians aged 15 and older during the COVID-19 pandemic.
methodsWe analyzed data from the 2022 Mental Health and Access to Care Survey (MHACS), a cross-sectional survey of Canadians aged 15 and older living in the 10 provinces (n = 9861). MHD and SUD were assessed using the WHO Composite International Diagnostic Interview. Respondents were classified into four groups: no disorder, MHD only, SUD only, and concurrent disorders. Multinomial logistic regression identified sociodemographic, health, and pandemic-related characteristics associated with these disorder categories, using survey weights and bootstrap methods.
resultsAmong respondents, 1.6% had concurrent disorders, 12.2% had a MHD only, and 1.6% had a SUD only. Younger adults, especially those aged 20 to 24, and 2SLGBTQI+ individuals had elevated risk for concurrent disorders. Additional correlates included lower education, rural residence, weak sense of belonging, and functional impairment. Pandemic-related stressors-loneliness, financial hardship, and difficulty accessing care-were strongly associated with concurrent disorders.
conclusionThis study highlights the prevalence and key correlates for MHD, SUD, and concurrent disorders among Canadian adults during the COVID-19 pandemic. Vulnerable populations include younger individuals, sexual and gender minorities, and those facing social isolation or unmet care needs. These findings underscore the importance of ensuring integrated, accessible mental health and substance use services in Canada's postpandemic recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.